Akeega (niraparib and abiraterone acetate) — Highmark

Initial criteria

• age ≥ 18 years
• diagnosis of mCRPC
• disease harbors a deleterious or suspected deleterious BRCA mutation per an FDA-approved companion diagnostic for Akeega
• Akeega is used in combination with prednisone
• member is concurrently receiving a gonadotropin-releasing hormone (GnRH) analog OR has had a bilateral orchiectomy